Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
belinostat (beleodaq) (1 trial)
Lymphoma (Phase 2)
Lymphoma, T-Cell (Phase 2)
Lymphoma, T-Cell, Peripheral (Phase 2)
Trials (1 total)
Trial APIs (1 total)